Novel psychoactive substances, also known as designer drugs, impose a major health risk and an economic threat worldwide. The extent of this problem has escalated exponentially in the recent years because of the parallel and exponential growth of the information and communication technology, and the electronic commerce (e-commerce) phenomenon (
1-
3). The chemical substance 25b-NBOMe (
Figure 1), also known as “N-Bomb” or “Smiles” signifying its high potency, is a phenethylamine derivative used for its “psychedelic” properties as a potent hallucinogen. It is a synthetic hallucinogenic compound; it belongs to the versatile spectra of novel psychoactive substances (NPS) (
4). 25b-NBOMe is a serotonergic agonist via acting on the 5HT2A receptors located in the nervous system. The hallucinogenic effect can manifest at tiny doses of micrograms, as little as 250 - 500 µg. Therefore, this substance or similar substances has been either banned or controlled in many regions of the world (
5-
8). Two other related compounds (
Figure 1), 25c-NBOMe and 25i-NBOMe, are even more potent and more popular worldwide (
7,
8).
Data from Google trends in the United Kingdom show a steady and persistent interest in 25b-NBOMe since 2010; there was also a sudden increment (spike) of interest occurring in October 2014. Comparable trends data showed a similar pattern worldwide. Another more potent and more popular related compound is 25I-NBOMe. This compound seems to be more popular on the internet (surface web) according to the data retrieved from Google trends (
Figure 2). These three NBOMe compounds differ primarily from each other in their halogen (Bromine, Chlorine, and Iodine) atom included within its molecule.
Based on a literature review of case reports of interest (
Table 1) on the PubMed/Medline database, NBOMe compounds seem to be used for recreational purposes, psychedelic/hallucinogenic experiences, and suicidal intentions (Suzuki et al., 2014); a couple of male-female ended in death (Walterscheid et al., 2014). The majority of users were males (84.6%), aged 15 to 23, although one victim of intoxication was a Chinese individual at the age of 31 years, representing a statistical outlier (Tang et al., 2014). The majority of NBOMe (ab) users were Caucasians from the United States (61.5%). Polypharmacy (poly-substance use) was calculated to be quite high (69.3%), and most cases ended in death (69.3%) despite receiving medical interventions. These fatalities were clustered in 2013, 2014, 2015, and 2016. The majority of these cases required admittance to emergency and intensive care units for life support, hydration, intubation and assisted ventilation. The less severe cases of intoxication were effectively managed using intravenous hydration, benzodiazepines (intravenous), anticholinergic agents, and other symptomatic and supportive measures (
9-
18).
The literature review for this manuscript was carried out across medical and paramedical databases including PubMed, cochrane library, Scopus, Google Scholar, and unpublished (grey) literature. In compliance with the classification system imposed by the oxford centre for evidence-based medicine, this manuscript level-of-evidence is categorized to be level-4 (
19).